Deferiere Raphael 4
4 · Centessa Pharmaceuticals plc · Filed Jun 3, 2025
Insider Transaction Report
Form 4
Deferiere Raphael
Chief Accounting Officer
Transactions
- Award
Share Option (right to buy)
2025-06-02+165,000→ 165,000 totalExercise: $13.41Exp: 2035-06-02→ Ordinary Shares (165,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to such option shall vest and become exercisable on June 2, 2026 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.